1. Market Research
  2. > Healthcare
  3. > Medical Device
  4. > In Vitro Diagnostics Market Trends
  5. > 2015 Strategies in the Global Therapeutic Drug Monitoring (TDM) Market

2015 Strategies in the Global Therapeutic Drug Monitoring (TDM) Market

  • May 2015
  • -
  • Venture Planning Group
  • -
  • 313 pages

Summary

Table of Contents

This new 313-page report contains 83 tables and provides analysis of the global therapeutic drug monitoring testing market, including emerging tests, technologies, instrumentation, sales forecasts by country, market shares, and strategic profiles of leading suppliers.

The report provides test volume and sales forecasts by country and market segment for the following assays:

Amikacin
Carbamazepine
Cyclosporin
Digoxin
Everolimus
Gentamicin
Levetiracetam
Lithium
Methotrexate
NAPA/Procainamide
Phenobarbital
Phenytoin
Quinidine
Sirolimus
Tacrolimus
Theophylline
Tobramycin
Topirimate
Valproic Acid
Vancomycin

During the next decade, the TDM market will undergo significant transformation.These changes will be caused by convergence of new and more stringent regulations; advances in diagnostic technologies, system engineering, automation, and IT; and intensifying competition.Some segments will start resembling commodity markets, where product positioning and cost per test are more critical than underlying technology.This evolving marketplace will create exciting opportunities for a variety of new instruments, reagent systems, and auxiliary products, such as specimen preparation devices, controls, calibrators and others.

"2014 Strategies for the Global Therapeutic Drug Monitoring (TDM) Market" is a unique worldwide market and technology assessment designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities and developed effective strategic responses.The study provides five-year forecasts for major TDM assays; compares features of leading analyzers; and profiles key competitors.

Contains 313 pages and 83 tables.

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 60 Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
Get This Report
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
2017 Competing in the Global Enteric Disease Testing Market

2017 Competing in the Global Enteric Disease Testing Market

  • $ 11500
  • Industry report
  • March 2017
  • by Venture Planning Group

Complete report $11,500.  DataPack (test volumes, sales forecasts, supplier shares) $7500. This new 389-page report from VPGMarketResearch.com contains 97 tables and provides analysis of the global enteric ...

2017-2021 Enteric Diseases Diagnostic Testing Market

2017-2021 Enteric Diseases Diagnostic Testing Market

  • $ 7500
  • Industry report
  • February 2017
  • by Venture Planning Group

Complete report $11,500.  DataPack (test volumes, sales forecasts, supplier shares) $7500. This new 389-page report from VPGMarketResearch.com contains 97 tables and provides analysis of the global enteric ...

2017-2021 Enteric Diseases: Campylobacter, Cryptosporidium, E. Coli, Enterovirus, Rhinovirus, Rotavirus, Salmonella, Shigella, Vibrio, Yersinia--Supplier Shares, Competitive Strategies

2017-2021 Enteric Diseases: Campylobacter, Cryptosporidium, E. Coli, Enterovirus, Rhinovirus, Rotavirus, Salmonella, Shigella, Vibrio, Yersinia--Supplier Shares, Competitive Strategies

  • $ 7500
  • Industry report
  • January 2017
  • by Venture Planning Group

About this Report This new 389-page report from VPGMarketResearch.com presents detailed analysis of the Enteric Disease market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan.  Current ...


ref:plp2015

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.